Fertility Supplements Market Segment Analysis – By Distribution Channel On the basis of distribution channel, the OTC segment accounted for the largest segmental revenue of the fertility supplements market in 2019 owing to the fact that the easy availability of raw materials, rising demand, and lenient regulations. In order to enter this highly competitive market, the companies need to focus on incorporating ingredients that have been regulated by the FDA and have undergone a significant number of clinical trials/studies. However, the prescribed segment is poised to hold the highest growth rate with a CAGR of 7.89% over the forecast period 2020-2025. This is attributed to the fact that the manufacturers endorse their products by providing clinical evidence for the ingredients included rather than focusing on the finished product. Hence, companies such as Fairhaven, Lenus Pharma, and Gonadosan, Innovamed Ltd. have provided evidence from the clinical trials of their finished products, which has resulted in an increased demand for fertility supplements across the globe.